Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Billaud

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
Cell Death Discovery|July 6, 2023
The TLR3 L412F polymorphism prevents TLR3-mediated tumor cell death induction in pediatric sarcomasJoseph Bisaccia, Swann Meyer, Adrien Bertrand-Chapel, et al.
Blood|November 14, 2022
BTG1 inactivation drives lymphomagenesis and promotes lymphoma dissemination through activation of BCAR1Lorric Delage, Mireille Lambert, Émilie Bardel, et al.
Neuro-Oncology|January 10, 2025
Establishing a living biobank of pediatric high-grade glioma and ependymoma suitable for cancer pharmacologyClémence Deligne, Arthur Tourbez, Flavie Bénard, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
Cell Death Discovery|July 6, 2023
The TLR3 L412F polymorphism prevents TLR3-mediated tumor cell death induction in pediatric sarcomasJoseph Bisaccia, Swann Meyer, Adrien Bertrand-Chapel, et al.
Blood|November 14, 2022
BTG1 inactivation drives lymphomagenesis and promotes lymphoma dissemination through activation of BCAR1Lorric Delage, Mireille Lambert, Émilie Bardel, et al.
Neuro-Oncology|January 10, 2025
Establishing a living biobank of pediatric high-grade glioma and ependymoma suitable for cancer pharmacologyClémence Deligne, Arthur Tourbez, Flavie Bénard, et al.
Pageof 6